• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人乳腺上皮细胞中模拟乳腺癌相关的c-Src和表皮生长因子受体(EGFR)过表达:c-Src和EGFR协同促进异常三维腺泡结构和侵袭行为。

Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior.

作者信息

Dimri Manjari, Naramura Mayumi, Duan Lei, Chen Jing, Ortega-Cava Cesar, Chen Gengsheng, Goswami Rasna, Fernandes Norvin, Gao Qingshen, Dimri Goberdhan P, Band Vimla, Band Hamid

机构信息

Division of Molecular Oncology, Evanston Northwestern Healthcare Research Institute, Evanston, IL 60201, USA.

出版信息

Cancer Res. 2007 May 1;67(9):4164-72. doi: 10.1158/0008-5472.CAN-06-2580.

DOI:10.1158/0008-5472.CAN-06-2580
PMID:17483327
Abstract

Epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor tyrosine kinases, is overexpressed in as many as 60% cases of breast and other cancers. EGFR overexpression is a characteristic of highly aggressive molecular subtypes of breast cancer with basal-like and BRCA1 mutant phenotypes distinct from ErbB2-overexpressing breast cancers. Yet, EGFR is substantially weaker compared with ErbB2 in promoting the oncogenic transformation of nontumorigenic human mammary epithelial cells (human MEC), suggesting a role for cooperating oncogenes. Here, we have modeled the co-overexpression of EGFR and a biologically and clinically relevant potential modifier c-Src in two distinct immortal but nontumorigenic human MECs. Using a combination of morphologic analysis and confocal imaging of polarity markers in three-dimensional Matrigel culture together with functional analyses of early oncogenic traits, we show for the first time that EGFR and c-Src co-overexpression but not EGFR or c-Src overexpression alone unleashes an oncogenic signaling program that leads to hyperproliferation and loss of polarity in three-dimensional acinar cultures, marked enhancement of migratory and invasive behavior, and anchorage-independent growth. Our results establish that EGFR overexpression in an appropriate context (modeled here using c-Src overexpression) can initiate oncogenic transformation of nontumorigenic human MECs and provide a suitable in vitro model to interrogate human breast cancer-relevant oncogenic signaling pathways initiated by overexpressed EGFR and to identify modifiers of EGFR-mediated breast oncogenesis.

摘要

表皮生长因子受体(EGFR)是受体酪氨酸激酶ErbB家族的成员之一,在多达60%的乳腺癌和其他癌症病例中过度表达。EGFR的过度表达是具有基底样和BRCA1突变表型的高侵袭性乳腺癌分子亚型的特征,这些亚型与ErbB2过表达的乳腺癌不同。然而,与ErbB2相比,EGFR在促进非致瘤性人乳腺上皮细胞(人MEC)的致癌转化方面要弱得多,这表明需要协同致癌基因发挥作用。在这里,我们在两种不同的永生化但非致瘤性人MEC中模拟了EGFR和一种生物学和临床相关的潜在调节因子c-Src的共表达。通过在三维基质胶培养中结合形态学分析和极性标记物的共聚焦成像以及早期致癌特征的功能分析,我们首次表明,EGFR和c-Src的共表达而非单独的EGFR或c-Src过表达会引发致癌信号程序,导致三维腺泡培养中的细胞过度增殖和极性丧失、迁移和侵袭行为显著增强以及不依赖贴壁生长。我们的结果表明,在适当的环境中(此处使用c-Src过表达进行模拟)EGFR的过表达可以启动非致瘤性人MEC的致癌转化,并提供一个合适的体外模型来研究由过表达的EGFR引发的与人类乳腺癌相关的致癌信号通路,并鉴定EGFR介导的乳腺肿瘤发生的调节因子。

相似文献

1
Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior.在人乳腺上皮细胞中模拟乳腺癌相关的c-Src和表皮生长因子受体(EGFR)过表达:c-Src和EGFR协同促进异常三维腺泡结构和侵袭行为。
Cancer Res. 2007 May 1;67(9):4164-72. doi: 10.1158/0008-5472.CAN-06-2580.
2
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.BRCA1 缺失导致乳腺上皮细胞中表皮生长因子受体表达增加,表皮生长因子受体抑制可预防 BRCA1 突变小鼠中雌激素受体阴性癌症。
Breast Cancer Res. 2011 Mar 11;13(2):R30. doi: 10.1186/bcr2850.
3
Functional analysis of Csk and CHK kinases in breast cancer cells.乳腺癌细胞中Csk和CHK激酶的功能分析
J Biol Chem. 2001 Sep 7;276(36):33711-20. doi: 10.1074/jbc.M104209200. Epub 2001 Jul 9.
4
Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.核受体辅调节因子富含脯氨酸、谷氨酸和亮氨酸蛋白1/雌激素受体非基因组作用调节因子的致癌潜力。
Cancer Res. 2007 Jun 1;67(11):5505-12. doi: 10.1158/0008-5472.CAN-06-3647.
5
Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.在乳腺癌细胞中,Met和c-Src协同作用以补偿表皮生长因子受体激酶活性的丧失。
Cancer Res. 2008 May 1;68(9):3314-22. doi: 10.1158/0008-5472.CAN-08-0132.
6
c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function.c-Src介导的表皮生长因子受体在酪氨酸845和酪氨酸1101位点的磷酸化与受体功能的调节相关。
J Biol Chem. 1999 Mar 19;274(12):8335-43. doi: 10.1074/jbc.274.12.8335.
7
Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells.Src 家族激酶介导乳腺癌细胞脂筏中表皮生长因子受体信号转导。
Cancer Biol Ther. 2011 Oct 15;12(8):718-26. doi: 10.4161/cbt.12.8.16907.
8
Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers.c-Src对表皮生长因子受体介导的肿瘤发生的增强作用:对多种人类癌症病因的启示
Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6981-5. doi: 10.1073/pnas.92.15.6981.
9
ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.ErbB2 需要整合素 α5 通过Src 调节人乳腺上皮细胞中受体活性来抵抗失巢凋亡。
J Cell Sci. 2010 Apr 15;123(Pt 8):1373-82. doi: 10.1242/jcs.050906. Epub 2010 Mar 23.
10
The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants.Src协同作用在非小细胞肺癌相关表皮生长因子受体突变介导的致癌转化中的作用
Oncogene. 2009 Apr 23;28(16):1821-32. doi: 10.1038/onc.2009.31. Epub 2009 Mar 23.

引用本文的文献

1
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models.表皮生长因子受体扩增和 EGFRvIII 预测并参与了 TAT-Cx43266-283 在临床前胶质母细胞瘤模型中的抗肿瘤反应。
Neuro Oncol. 2024 Jul 5;26(7):1230-1246. doi: 10.1093/neuonc/noae060.
2
c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?分子癌症治疗中c-Src和表皮生长因子受体(EGFR)抑制:我们还能改进什么?
Cancers (Basel). 2020 Jun 7;12(6):1489. doi: 10.3390/cancers12061489.
3
AGO2 phosphorylation by c-Src kinase promotes tumorigenesis.
AGO2 磷酸化可被 c-Src 激酶促进肿瘤发生。
Neoplasia. 2020 Mar;22(3):129-141. doi: 10.1016/j.neo.2019.12.004. Epub 2020 Jan 22.
4
EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling.EHD1 和 RUSC2 控制基础表皮生长因子受体的细胞表面表达和再循环。
Mol Cell Biol. 2020 Mar 16;40(7). doi: 10.1128/MCB.00434-19.
5
The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion.同源受体 PTPRK 选择性去磷酸化多个连接调节剂,以促进细胞-细胞黏附。
Elife. 2019 Mar 29;8:e44597. doi: 10.7554/eLife.44597.
6
Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells.达沙替尼通过靶向乳腺癌干细胞使三阴性乳腺癌细胞对化疗敏感。
Br J Cancer. 2018 Dec;119(12):1495-1507. doi: 10.1038/s41416-018-0287-3. Epub 2018 Nov 28.
7
Cooperates with Oncogenic in Tumourigenesis via the JNK and PI3K Pathways in epithelial Tissue.在 上皮组织中通过 JNK 和 PI3K 通路与致癌基因协同作用促进肿瘤发生。
Int J Mol Sci. 2018 May 27;19(6):1585. doi: 10.3390/ijms19061585.
8
Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers.丝裂原活化蛋白激酶(MAPK)在乳腺癌中的临床病理及预后意义
Breast Cancer Res Treat. 2016 Oct;159(3):457-67. doi: 10.1007/s10549-016-3967-9. Epub 2016 Sep 3.
9
A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.一个miR-200c/141-BMI1自调控环调节癌细胞中BMI1的致癌活性。
Oncotarget. 2016 Jun 14;7(24):36220-36234. doi: 10.18632/oncotarget.8811.
10
EGF-receptor specificity for phosphotyrosine-primed substrates provides signal integration with Src.表皮生长因子受体对磷酸酪氨酸引发底物的特异性提供了与Src的信号整合。
Nat Struct Mol Biol. 2015 Dec;22(12):983-90. doi: 10.1038/nsmb.3117. Epub 2015 Nov 9.